Schizophrenia patients have more copy number variations (CNVs) than healthy controls, and reduced brain volumes. Although this could suggest a causal relationship, we found no association between global CNV burden and three brain volume measures (on a MRI scan) in a sample of 173 schizophrenia patients and 176 healthy controls.
Introduction
The heritability of schizophrenia is around 80% (Cardno et al., 1999) , but the underlying genetic determinants are largely unknown. Copy number variants (CNVs) are genomic microdeletions or microduplications from 1 kb to multiple Mb in size. These can disrupt genes and thereby change mRNA and protein levels, possibly resulting in disease (Sutrala et al., 2007 ). An excess of rare CNVs was found in schizophrenia (15%) compared to healthy controls (5%) (Walsh et al., 2008) . Our group previously reported a significantly higher burden of deletions in schizophrenia patients compared to healthy controls (Buizer-Voskamp et al., 2011) . Several specific deletions related to schizophrenia, e.g. on chromosome location 1q21.1 and 22q11, were previously shown to be associated with neuroanatomical abnormalities such as reduced total brain volumes (Brunetti-Pierri et al., 2008; Zinkstok and Amelsvoort, 2005) . Total brain volume is highly heritable (80-90%) (Baare et al., 2001 ) and patients with schizophrenia have on average 3% smaller brain volumes compared to healthy controls (Wright et al., 2000) . Investigating the genetic factors underlying brain volume reductions can increase insight into the pathophysiology of schizophrenia. Our group previously reported that white matter loss in schizophrenia patients was largely (94%) attributable to genetic factors, while gray matter volume was determined by unique and common environmental factors (Haren et al., in press ). We therefore investigated the association between global CNV burden and total brain, white matter and gray matter volume in schizophrenia patients and healthy controls.
Methods and materials

Subjects
The sample consisted of 173 patients (158 with schizophrenia, and 15 with schizoaffective disorder) and 176 controls. Psychopathology was assessed using the Comprehensive Assessment of Symptoms and History (Andreasen et al., 1992) . Unaffected subjects had no history of psychiatric illness except for three subjects who had a history of anxiety disorder, obsessive-compulsive disorder and adjustment disorder. None of the control subjects had first-degree family members with psychotic illness.
Magnetic resonance imaging
Brain images were acquired on Philips NT and Philips Achieva scanners at 1.5 T. MRI acquisition and processing methods have been previously described (Hulshoff Pol et al., 2002) . Post-processing was done on the neuro-imaging computer network at our department. Images were coded to ensure blind measurements. Total brain, white matter and gray matter volume were corrected for intracranial volume, age and sex by taking the unstandardized residuals using linear regression.
Genotyping
Subjects were genotyped at the University of California in Los Angeles on the Illumina HumanHap550 beadchip. CNVs were determined from SNP data using the QuantiSNP and PennCNV algorithms as described previously (Buizer-Voskamp et al., 2011) . Deviations for 10 consecutive SNPs were regarded as CNVs. Refseq genes within 50 kb of the CNV borders were counted using the March 2006 assembly on the UCSC browser (http://genome.ucsc.edu). Brain expression was determined using expressed sequence tag data of brain tissue in the UCSC browser. Total numbers of CNVs affecting genes, genes affected by CNVs and brain expressed genes affected by CNVs were calculated.
Statistical analyses
Above a certain cut-off point (3þ , 4þ or 5þ , depending on the frequency distribution) numbers of CNVs were combined to obtain categories of at least 20 subjects (see Supplementary Table 1) . First, the 3 CNV measures were used as factors (one-by-one) in ANOVAs with the unstandardized residuals of the brain volume measures as dependent variables in the total sample. Second, to study if the impact of CNVs on brain volume differs between patients and controls, disease status and CNV n disease status interaction were included in the analyses. All analyses were repeated for deletions and duplications separately.
Results
There were significantly more males in the patient group than in the control group (80% vs. 54% male, po0.0001). The groups did not differ in age and parental education (an estimate for socioeconomic status). Total brain volume was significantly smaller in patients (mean 1482.1 ml, sd 50.8) than in controls (mean 1505.4 ml, sd 43.7; p¼5.3 Â 10 À 6 ), as were gray matter and white matter volume. After correction for multiple comparisons (a ¼0.003 (¼0.05/18 (3 brain volumes Â 3 'independent' CNV measures Â 2 tests))), none of the CNV measures showed a significant association with total brain volume, as shown (Table 1) .
Discussion
The results suggest that global CNV burden does not exert major effects on brain volume in schizophrenia patients nor in healthy controls. We had 80% power to detect a CNV measure explaining 4.3% of the variance in total brain volume with a 0.003.
Although the effect of CNVs might be larger than the effect of SNPs and quantitative phenotypes have more power than dichotomous disease traits (Potkin et al., 2009) , the combined effects of CNVs may still have been too small to detect in our sample. If only a limited number of specific CNVs have an impact on brain development, these could be missed by analyzing global CNV burden. Alternatively, CNVs might have regional effects on brain volume that could go undetected by using global brain volume measures. Replication of this negative finding is essential, and for this purpose our raw data are available on request. Should replication studies also fail to demonstrate an association between CNV burden and brain volume, another possible explanation is that CNVs and brain volume are independently associated with schizophrenia, or that at least one of them is associated to schizophrenia through a confounder. Table 1 Association results of CNVs with brain volumes. P main is the effect of the CNV in the total sample. P interaction is the interaction with disease status, which is equivalent to the difference in effect in the patient and control groups. P-values are not corrected for multiple testing. 
